Home > Products > Biosimilars

BioSIM anti-Human PD-L1/CD274 Antibody (Avelumab Biosimilar), Research Grade

Catalog: SIM0048
Cost advantage to: SIM0021
Isotype: IgG1-lambda
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic biosimilar uses Avelumab’s variable regions, ideal for research. It reacts with human PD-L1 (B7-H1/CD274, a 40 kDa type I transmembrane protein in B7/Ig superfamily) expressed on various cells. PD-L1 binding to PD-1 inhibits TCR-mediated T cell proliferation/cytokine production, aiding tumor immune evasion. Avelumab blocks PD-L1’s interaction with PD-1 and CD80.
 

Specifications

Product Name BioSIM anti-Human PD-L1/CD274 Antibody (Avelumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG1-lambda
Target PD-L1/CD274
Other Names MSB-0010718C, MSB0010682, CAS: 1537032-82-8
CAS 1537032-82-8
Reactivity Human
Host Species Human
Background This non-therapeutic biosimilar uses Avelumab’s variable regions, ideal for research. It reacts with human PD-L1 (B7-H1/CD274, a 40 kDa type I transmembrane protein in B7/Ig superfamily) expressed on various cells. PD-L1 binding to PD-1 inhibits TCR-mediated T cell proliferation/cytokine production, aiding tumor immune evasion. Avelumab blocks PD-L1’s interaction with PD-1 and CD80.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products